Skip to main content

Table 2 Clinical and genetic data for the 9 successfully amplified cases with PACC

From: Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 in primary pulmonary adenoid cystic carcinoma

No. Age (y) Gender Location Genetic mutation
EGFR KRAS BRAF PIK3CA ALK DDR2 PDGFRA
1 38 M Trachea (upper 1/3) - - - - - - -
2 56 F Trachea (upper 1/3) - - - - - - -
3 35 F Trachea (lower 1/3) - - - - - - -
4 60 F Trachea (lower 1/3) - - - - - - -
5 51 F Trachea (lower 1/3) - - - - - - -
6 57 F Trachea (upper 1/3) - - - - - - -
7 62 F Trachea (middle 1/3) - - - - - - -
8 74 F Trachea (upper 1/3) - - - - - - -
9 46 F Trachea (lower 1/3) - - - - - - -